Market News

Evercore ISI Group analyst Daniel Markowitz maintains Natera (NASDAQ:NTRA) with a Outperform and lowers the price target from $468 to $400.

IRVING, Texas (AP) — IRVING, Texas (AP) — Fluor Corp. (FLR) on Friday reported profit of $158 million in its third quarter.

Nvidia stock was recouping some of its losses on Friday. Here's what's fueling the positivity.

Evercore ISI Group analyst Mark Lipacis maintains MACOM Technology Solns (NASDAQ:MTSI) with a Outperform and lowers the price target from $475 to $...

Algonquin Power & Utilities Corp. (AQN:CA) Q3 2026 Earnings Call November 6, 2026 8:30 AM ESTCompany ParticipantsBrian Chin - Vice President of Invest...

Investing.com -- U.S. chip stocks rebounded in premarket trading Friday, recovering some ground after a sweeping AI-driven selloff Thursday that follo...

Investing.com -- U.S. chip stocks rebounded in premarket trading Friday, recovering some ground after a sweeping AI-driven selloff Thursday that follo...

Wells Fargo analyst Jason Haas maintains Verisk Analytics (NASDAQ:VRSK) with a Overweight and raises the price target from $260 to $265.

Evercore ISI Group analyst Mark Mahaney maintains Magnite (NASDAQ:MGNI) with a Outperform and raises the price target from $25 to $33.

Evercore ISI Group analyst Mark Lipacis maintains Microchip Technology (NASDAQ:MCHP) with a Outperform and lowers the price target from $117 to $75...

Wells Fargo analyst Yanan Zhu maintains Fate Therapeutics (NASDAQ:FATE) with a Equal-Weight and lowers the price target from $3.5 to $3.

https://x.com/AlArabiya_Eng/status/2118716041874358728

PayPal CEO Enrique Lores sits down with CNBC's Sara Eisen to discuss the company's turnaround plan, cost-cutting measures, and more.

Colorectal cancer: in a human liver-metastasis organoid model resistant to botensilimab and balstilimab alone, the addition of agenT-797 supported imm...

Evercore ISI Group analyst Michael Griffin maintains Macerich (NYSE:MAC) with a Outperform and raises the price target from $25 to $27.

Wells Fargo analyst Yanan Zhu maintains BeOne Medicines (NASDAQ:ONC) with a Overweight and raises the price target from $400 to $435.

Concentra Group Holdings (NYSE:CON) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call ...

Evercore ISI Group analyst Mark Mahaney maintains Lyft (NASDAQ:LYFT) with a In-Line and lowers the price target from $21 to $20.

Advanced Micro Devices' 35% selloff created a nice buying opportunity, as its Data Center segment has doubled in just one year. Read more on AMD stock...

Evercore ISI Group analyst Glenn Schorr maintains Invesco (NYSE:IVZ) with a In-Line and lowers the price target from $34 to $33.